SMTL ID : 9fpd.1

Crystal structure of human TAK1/TAB1 fusion protein in complex with compound S1

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x 01: 6-[5-[6-(4-oxidanylcyclohexyl)oxy-1~{H}-pyrrolo[2,3-b]pyridin-5-yl]-1,2-oxazol-3-yl]pyridine-2-carboxamide

01.1: 19 residues within 4Å: Chain A: V.18, G.19, R.20, G.21, V.26, A.37, K.39, E.53, V.66, M.80, E.81, Y.82, A.83, E.84, G.86, S.87, L.139, C.150, D.151 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:V.18, A:V.26, A:A.37, A:V.66, A:M.80, A:Y.82, A:L.139, A:L.139 Hydrogen bonds: A:K.39, A:A.83, A:D.151, A:D.151, A:D.151

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 5 residues within 4Å: Chain A: R.241, S.248, Q.249, R.250, E.255 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.241, A:Q.249 EDO.3: 5 residues within 4Å: Chain A: P.97, L.274, Q.275, Y.276, P.277 No protein-ligand interaction detected (PLIP) EDO.4: 4 residues within 4Å: Chain A: S.108, Q.112, T.145, D.271 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.112, A:T.145

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Langlois, J.B. et al., Identification of TAK-756, A Potent TAK1 Inhibitor for the Treatment of Osteoarthritis through Intra-Articular Administration. J.Med.Chem. (2024)

Release Date

2024-12-04

Peptides

Mitogen-activated protein kinase kinase kinase 7,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase kinase kinase 7,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1